Ignite Creation Date:
2024-05-06 @ 8:57 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02860286
Status:
COMPLETED
Last Update Posted:
2021-04-09
First Post:
2016-07-27
Brief Title:
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Sponsor:
Epizyme Inc
Organization:
Epizyme Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07
Start Date Type:
None
Primary Completion Date:
2018-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-27
First Submit QC Date:
August 4 2016
Study First Post Date:
2016-08-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-04-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-16
Last Update Post Date:
2021-04-09
Last Update Post Date Type:
ACTUAL